Jodie Vogtman
Surgical · Havre de Grace, MDNPI 1285656249
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,447 of the $8,761 with a category attached, or 85.0%. 32 manufacturers reported payments, led by AbbVie at 29.6% of the total. Reporting peaked in 2024 at $3,283 and has fallen 62.2% since, to $1,240 in 2025. Among surgical clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 364 payments — averaging $24.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Nalu Medical, Inc.$2K
- Lundbeck LLC$606
- Pfizer$541
- Collegium Pharmaceutical, Inc.$507
- Averitas Pharma Inc.$359
- plus $2K from 26 others
What the payments were for
- Travel & lodging$1,31515%
- Food & beverage$7,44785%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 147 | $2,596 |
| Nalu Medical, Inc. | 17 | $1,786 |
| Lundbeck LLC | 23 | $606 |
| Pfizer | 28 | $541 |
| Collegium Pharmaceutical, Inc. | 25 | $507 |
| Averitas Pharma Inc. | 13 | $359 |
| IBSA Pharma Inc. | 12 | $273 |
| Abbott | 11 | $223 |
| Biohaven Pharmaceutical Holding Company Ltd. | 11 | $222 |
| GRT US Holding, Inc. | 11 | $208 |
| Lilly USA, LLC | 9 | $163 |
| Boston Scientific | 7 | $160 |
| Biohaven Pharmaceuticals, Inc. | 9 | $147 |
| Pacira Therapeutics, Inc. | 4 | $130 |
| Amgen(2 entities) | 5 | $113 |
| Johnson & Johnson | 3 | $83 |
| Nevro Corp. | 3 | $73 |
| Vertos Medical, Inc. | 2 | $69 |
| Pacira Pharmaceuticals Incorporated | 3 | $66 |
| Vertex | 4 | $58 |
| Si-bone, Inc. | 2 | $54 |
| Stryker | 2 | $44 |
| Bioventus LLC | 1 | $37 |
| Arbor Pharmaceuticals, Inc. | 2 | $34 |
| Medtronic | 2 | $34 |
| Fidia Pharma USA Inc. | 2 | $31 |
| International Rehabilitative Sciences, Inc | 1 | $29 |
| Saluda Medical Americas, Inc. | 1 | $28 |
| Avanos Medical | 1 | $25 |
| Curonix LLC | 1 | $23 |
| Globus Medical | 1 | $20 |
| Scilex Pharmaceuticals Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Nalu Neurostimulation System$1,442
- UBRELVY$108
How this compares
$8,761 in reported general payments places this provider in the 95th percentile of 277 surgical providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 84 | $36,566 |
| UbrelvyUbrogepant | 15 | $23,497 |
| BelbucaBuprenorphine Hcl | 28 | $18,843 |
| OxycontinOxycodone Hcl | 29 | $9,905 |
| Hysingla ErHydrocodone Bitartrate | 11 | $8,975 |
| Pregabalin | 297 | $8,648 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 369 | $7,206 |
| Oxycodone Hcl | 565 | $7,146 |
| Buprenorphine | 25 | $7,067 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 324 | $6,858 |
| ButransBuprenorphine | 12 | $6,102 |
| Naloxone Hcl | 89 | $5,903 |
| Gabapentin | 205 | $5,283 |
| Morphine Sulfate ErMorphine Sulfate | 203 | $3,710 |
| Methocarbamol | 99 | $1,950 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca | $507 | $55,409112 claims |
| AbbVieUbrelvy | $2,596 | $23,49715 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 277 surgical providers in Maryland.
Other surgical in Havre de Grace
- Jenifer AbbottHavre de Grace$9K
- Christina BulleyPotomac$39K
- Erika NigamBaltimore$8K
- Tara MorrisBaltimore$7K
- Megan BellGlen Burnie$7K
- Simone BeattieBaltimore$7K
- Marla MuhaGlen Burnie$5K
- Amanda PanfilCheverly$5K
- Virginia OrlovAnnapolis$5K
- Cairo KeenanBaltimore$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.